Skip to main content

DavidJAskenaziMDMSPH

Pediatric Nephrology • Birmingham, AL

Professor, Pediatrics, University of Alabama at Birmingham School of Medicine

Join to view full profile

Dr. Askenazi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Askenazi's full profile

Already have an account?

  • Office

    1600 7th Ave S
    Birmingham, AL 35233
    Phone+1 205-939-9781

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Nephrology, 2002 - 2005
  • University of Texas at Austin Dell Medical School
    University of Texas at Austin Dell Medical SchoolResidency, Pediatrics, 2000 - 2002
  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsInternship, Pediatrics, 1998 - 1999
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1998

Publications & Presentations

PubMed

Journal Articles

  • Correction to: Acute Kidney Injury in Neonatal Encephalopathy: An Evaluation of the AWAKEN Database  
    Danielle E Soranno, Jason Gien, Megan J Kirkley, David Askenazi, Katja M Gist, Pediatric Nephrology
  • Maternal and Environmental Risk Factors for Neonatal AKI and Its Long-Term Consequences  
    David Askenazi, MD, Nature
  • Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates  
    Jennifer R Charlton, J Bryan Carmody, Matthew W Harer, David J Askenazi, Ronnie Guillet, David T Selewski, Jonathan R Swanson, JAMA
  • Join now to see all

Press Mentions

  • #NephMadness 2022: Novel Devices in Neonatal Nephrology – the Times They Are a-changing
    #NephMadness 2022: Novel Devices in Neonatal Nephrology – the Times They Are a-changingApril 7th, 2022
  • Nuwellis to Develop Pediatric Renal Replacement Therapy Device with $1.7 Million NIH Grant
    Nuwellis to Develop Pediatric Renal Replacement Therapy Device with $1.7 Million NIH GrantAugust 6th, 2021
  • Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH Grant
    Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH GrantAugust 5th, 2021
  • Join now to see all

Dr. David Askenazi, Dr. David Askenazi, MD, Dr. D Askenazi, Dr. David J Askenazi